TSA-II – NeuroSensory Analyzer
An essential Quantitative Sensory Testing () tool for evaluating nerve impairment and sensory testing in clinical, research and settings
What is TSA-II?
What would the results show?
A deviation from the normal range can indicate the existence of peripheral nerve disease or damage due to injury, illness or toxic exposure. Testing comparing contra-lateral body sites and longitudinal (or serial) evaluation before and after therapy can also be routinely employed.
- Outcome-based color graphic reports with automated narrative discussion of test results for insurance and referral networks
- Automatic comparison of test results to normative reference data
- Portable, fast set-up and ease of use
- Versatile WINDOWST based software with selection of test paradigms for maximum flexibility in clinical, research and drug trial applications.
- Various test methods (Limits, Levels and Manual)
- Factory installed default protocols for immediate clinical use
- Proven Repeatability
Useful in monitoring, treating and testing in:
- Painful neuropathies
- Lumbar Radiculopathy
- Small-fiber allodynia in Complex Regional Pain Syndrome (CRPS)
- Underlying Central Nervous System impairment in difficult-to-diagnose patients
- Early detection of diabetic neuropathy of small-caliber nerve fibers
- Effectiveness of growth factors, aldosereductase
- Inhibitors and other new therapies
- Entrapment and toxic neuropathies
- Testing programs to detect malingerers
- Nerve root compression and inflammation